Abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic T and NK cells that express the inhibitory immune checkpoint receptor KLRG1 (killer cell lectin-like receptor G1). The company is advancing ABC008, a first-in-class anti-KLRG1 antibody designed to deplete cytotoxic T cells that attack healthy muscle tissue in patients with inclusion body myositis (IBM), into clinical studies.

Biotechnology

Abcuro

Abcuro's headquarters in Newton, MA, United States

Alex Martin

Karen Tubridy

H. Jeffrey Wilkins, MD

Courtney Cupples

George Eldridge

Jeff Geary

Rajeev Shah

Steven A Greenberg

Jay Knowles

Jason P. Hafler

Tomer Kariv

Dietmar Berger

Yajun Xu

Jonah Cashdan

Ming Fang

Mark Pruzanski

Mike Dybbs

The Management and Directors team at Abcuro oversees strategic decision-making, operations, program management, analytical development, and human resources. This team ensures that the company's clinical advancements, such as the ABC008 anti-KLRG1 antibody, align with overall business objectives and regulatory standards to effectively treat autoimmune and cancer indications.

Management and Directors

The Leadership Team at Abcuro is responsible for strategic direction and oversight of the company's clinical development initiatives, particularly focusing on innovative therapies for autoimmune diseases and cancer. This team, comprising experts in research, clinical science, and regulatory affairs, collaborates to drive the advancement of ABC008 and ensure compliance with regulatory standards while fostering interdisciplinary communication to facilitate successful clinical trials. Their leadership is crucial in navigating the complex landscape of biotechnology and ensuring the company meets its scientific and therapeutic goals.

Leadership Team

The Quality and Regulatory Team at Abcuro ensures that clinical trials and product development meet stringent regulatory standards and quality assurance protocols. This team is responsible for regulatory submissions, maintaining compliance with Good Manufacturing Practices (GMP), overseeing quality control systems, and ensuring the highest quality standards in drug development. They play a critical role in advancing ABC008 through clinical stages while adhering to industry regulations and maintaining product integrity.

Quality and Regulatory Team

The Supply Chain and Manufacturing team at Abcuro is responsible for overseeing the production and distribution of ABC008 and other therapeutic products. This team ensures the efficient and compliant manufacturing of clinical-grade compounds, manages logistics and supply chain operations, and coordinates the end-to-end process from raw material sourcing to product delivery. They play a crucial role in advancing Abcuro's clinical trials by ensuring that high-quality treatment materials are available as needed.

Supply Chain and Manufacturing

The Clinical Operations Team at Abcuro is responsible for overseeing the execution and management of clinical trials, ensuring regulatory compliance, and coordinating cross-functional efforts to advance ABC008 through its clinical studies. This team manages all aspects of clinical trial operations, including site selection, patient recruitment, data collection, and trial monitoring to ensure the trials are conducted efficiently and effectively, thereby supporting the development of new therapies for autoimmune and cancer indications.

Clinical Operations Team

This department sets the strategic direction and overall management of the organization.

Abcuro

Org chart

Board & advisors

Teams

Management and Directors

Leadership Team

Quality and Regulatory Team

Supply Chain and Manufacturing

Clinical Operations Team

Executive Leadership

Offices

Abcuro

Org chart

Board & advisors

Teams

Management and Directors

Leadership Team

Quality and Regulatory Team

Supply Chain and Manufacturing

Clinical Operations Team

Executive Leadership

Offices

Related companies